Skip to main content
Krsnaa Diagnostics Limited logo

Krsnaa Diagnostics Limited — Investor Relations & Filings

Ticker · KRSNAA ISIN · INE08LI01020 LEI · 335800BHDTJRKNTQ1O55 BSE.NS Human health and social work activities
Open in API
Filings indexed 624 across all filing types
Latest filing 2026-01-28 Regulatory Filings
Country IN India
Listing BSE.NS KRSNAA

About Krsnaa Diagnostics Limited

https://krsnaadiagnostics.com/

Krsnaa Diagnostics Limited is a specialized provider of diagnostic services, focusing on radiology and pathology. The company operates an extensive network of centers, primarily utilizing a Public-Private Partnership (PPP) model to deliver medical imaging and laboratory services. Its radiology portfolio includes Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, X-rays, and Mammography, while its pathology division offers a wide array of clinical laboratory tests. A core technical feature is its integrated tele-radiology platform, which facilitates remote image interpretation by specialists to ensure rapid reporting. The company emphasizes high-quality, affordable diagnostics, targeting both public health systems and private patients. Its operational model is built on large-scale infrastructure and advanced technological integration to provide accessible diagnostic solutions across diverse geographic regions.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice to stock exchanges about an upcoming Board Meeting scheduled for February 5, 2026, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. It is a regulatory disclosure under SEBI (LODR) Regulations, specifically Regulation 29, which pertains to Board Meeting notices. The document does not contain any financial data or detailed reports but is an announcement of a meeting where financial results will be considered. The document length is short (1479 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2026-01-28 English
Resignation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the resignation of a key managerial personnel, specifically the Chief Financial Officer, Mr. Pawan Daga. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the resignation and cessation date. There is no financial data, audit information, or report content. The document is an announcement of a change in senior management, fitting the category of Board/Management Information (MANG). The document length is 3431 characters, which is consistent with a formal announcement rather than a full report.
2026-01-15 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the conversion of the company's statutory auditor's firm into a Limited Liability Partnership (LLP). It informs about the change in the auditor firm's name and requests the exchanges to take note. There is no financial data, no report attached or referenced as being published, no voting results, no management or board changes, no earnings or capital updates. The content is regulatory in nature, providing compliance information to the exchanges. The document length is short (1393 characters), and it is an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regarding an upcoming Analyst / Institutional Investor Meeting. It provides details about the meeting date, venue, participants, and mode of interaction. The document explicitly states that discussions will be based on publicly available information and no unpublished price sensitive information will be discussed. There is no financial data, report content, or detailed presentation included. The document serves as a notification or announcement about the meeting rather than the meeting materials or transcript itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-01-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about a scheduled meeting between company officials and investors/analysts. It explicitly states that discussions will be based on publicly available information and no unpublished price sensitive information will be discussed. The document is a notification of an upcoming investor/analyst meeting rather than the content or transcript of the meeting itself. It does not contain financial data, report content, or detailed presentation materials. Therefore, it fits the category of an Investor Presentation announcement or meeting notice. Given the options, the best fit is 'Investor Presentation (IP)' as it relates to investor-focused meetings and presentations, even though this is a notice rather than the presentation itself. The document length is short (1717 characters), and it is a formal regulatory announcement of an investor meeting, not a report or transcript. Confidence is high due to clear regulatory reference and content type.
2026-01-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31, 2025. It is a confirmation certificate issued by the Registrar and Share Transfer Agent certifying that details of securities dematerialized/rematerialized have been furnished to stock exchanges. The document is short (3505 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion. It is not an announcement of a report but a regulatory filing confirming compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS).
2026-01-06 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.